Understanding the molecular regulation of autophagy during aging
了解衰老过程中自噬的分子调控
基本信息
- 批准号:9374136
- 负责人:
- 金额:$ 25.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-01 至 2019-05-31
- 项目状态:已结题
- 来源:
- 关键词:AcetylationAgeAge of OnsetAgingArginineAutophagocytosisAutophagosomeBindingBiochemicalCellsCis-Acting SequenceDevelopmentDiseaseElementsFRAP1 geneFailureFatty acid glycerol estersFibronectinsGenesGeneticGenetic TranslationGoalsHalf-LifeHumanIn VitroIndividualKnock-outLightLipidsLiverLongevityMalignant NeoplasmsMediatingMembrane LipidsMessenger RNAMetabolic DiseasesMetabolic syndromeMetabolismMolecularMusMutagenesisMutant Strains MiceNerve DegenerationOrganellesPIK3CG genePathologyPathway interactionsPhosphotransferasesPlayPost-Translational Protein ProcessingProteinsProteomicsQuality ControlRNARNA BindingRegulationRiskRoleSequence AnalysisStarvationStressTestingTranscriptTransgenic Organismsage relatedagedcis acting elementdisorder preventionfeedingin vivoinsightmRNA Stabilitymutantnovelnovel strategiesoverexpressionpreventprotein aggregatereconstitutionrestorationsarcopenia
项目摘要
Abstract
The remarkable increase in human longevity over the last century has, unfortunately, increased the risk
of developing a number of age-related conditions, which underscores the need to develop strategies to
extend human healthspan. Cells recycle their damaged organelles and protein aggregates via
autophagy whereby cytoplasmic components are sequestered within autophagosomes (APh) and
targeted for lysosomal degradation. Briefly, class III PI3K, ULK1 kinase, and a conjugation cascade
involving core autophagy-related (ATG) proteins, ATG7, ATG5, ATG12, ATG16L1 and ATG8/light chain
3 (LC3) regulate autophagosome (APh) formation by lipidating cytosolic LC3-I into APh-bound LC3-II.
Aging associates with autophagy failure, which is a critical factor in the development of age-associated
conditions. How autophagy decreases with age remains unclear. While sustained mTOR activation,
altered membrane lipid composition, and acetylation of core ATG proteins each contribute to autophagy
failure; none of these mechanisms can completely explain why ATG proteins decrease with age. We
have found that LC3, a structural component of APh, binds to Atg16l1 mRNA. LC3 has recently been
shown to bind and enhance fibronectin mRNA translation – thus revealing a novel role of LC3 in RNA
metabolism. Our preliminary analyses revealed that starvation, which activates autophagy, leads to
increased LC3-Atg16l1 mRNA binding. Livers knocked out for Atg7 (that do not form LC3-II), and livers
from aged mice, each display loss of LC3-Atg16l1 mRNA binding, suggesting that LC3-II, and not LC3-
I, binds to Atg16l1 mRNA. In addition, overexpression of LC3 enhances ATG16L1 protein half-life.
Furthermore, Atg16l1 mRNA sequence analysis revealed presence of several AU-rich elements (ARE),
which are cis-acting sequences known to facilitate binding of RNA to specific proteins. These
observations have led to our hypothesis that LC3 binds to Atg16l1 mRNA in a feed-forward regulatory
loop that stabilizes Atg16l1 mRNA, and thereby maintains ATG16L1 protein levels and autophagy. We
hypothesize further that disruption of this regulatory loop contributes to autophagy failure. The overall
goal of this proposal is to: 1) examine whether age-associated decrease in LC3-Atg16l1 mRNA binding
leads to decreased Atg16l1 mRNA levels and autophagy failure, 2) determine the mechanism of LC3-
mediated Atg16l1 mRNA stability by using novel LC3 mutants in vitro, and a novel RRRLC3QQQ mutant
mouse wherein a triple arginine (RRR) motif in LC3, which we propose allows LC3-Atg16l1 mRNA
binding, has been inactivated, and 3) test whether genetic reconstitution of LC3-II in aged livers can
restore Atg16l1 mRNA levels, autophagy, and lipohomeostasis. Our studies will provide new
mechanistic insight into how autophagy decreases with age, and provide a novel strategy to prevent the
decline of this important quality control pathway with age.
Significance: Aged individuals are at increased risk for developing a number of diseases,
neurodegeneration, metabolic syndrome, and cancers, to mention a few. Studies of the loss of
autophagy in young mice or genetic overexpression of specific Atg genes in mice have shown the
critical role of autophagy in disease prevention. How autophagy decreases with age remains unclear.
Our studies will reveal a new mechanism of regulating autophagy by enhancing the stability of an Atg
mRNA, Atg16l1, by an ATG protein, LC3. Understanding how autophagy decreases with age is critical
for the development of new strategies to extend human healthspan – the number of years one remains
healthy and active.
摘要
不幸的是,在过去的世纪里,人类寿命的显著延长增加了这种风险。
发展一些与年龄有关的条件,这强调需要制定战略,
延长人类的健康寿命。细胞通过以下途径回收它们受损的细胞器和蛋白质聚集体:
自噬,其中细胞质组分被隔离在自噬体内(APh),
靶向溶酶体降解。简而言之,III类PI 3 K、ULK 1激酶和缀合级联
涉及核心自噬相关(ATG)蛋白、ATG 7、ATG 5、ATG 12、ATG 16 L1和ATG 8/轻链
3(LC 3)通过将胞质LC 3-I脂化为APh结合的LC 3-II来调节自噬体(APh)的形成。
衰老与自噬失败有关,自噬失败是年龄相关性肿瘤发生的关键因素。
条件自噬如何随着年龄的增长而减少仍不清楚。在持续mTOR激活的同时,
改变的膜脂质组成和核心ATG蛋白的乙酰化都有助于自噬
这些机制都不能完全解释为什么ATG蛋白随着年龄的增长而减少。我们
已经发现LC 3,APh的结构组分,与Atg 16 l1 mRNA结合。LC 3最近
显示结合并增强纤连蛋白mRNA翻译-从而揭示LC 3在RNA中的新作用
新陈代谢.我们的初步分析表明,饥饿,激活自噬,导致
增加LC 3-Atg 16 l1 mRNA结合。敲除Atg 7的肝脏(不形成LC 3-II),以及
来自老年小鼠的LC 3-Atg 16 l1 mRNA结合均丧失,表明LC 3-II而非LC 3-
I结合Atg 16 l1 mRNA。此外,LC 3的过表达增强了ATG 16 L1蛋白的半衰期。
此外,Atg 16 l1 mRNA序列分析显示存在几种富含AU的元件(ARE),
其是已知促进RNA与特定蛋白质结合的顺式作用序列。这些
观察导致我们的假设,LC 3结合Atg 16 l1 mRNA的前馈调节
稳定Atg 16 l1 mRNA的环,从而维持ATG 16 L1蛋白水平和自噬。我们
进一步假设该调节环的破坏有助于自噬失败。整体
本研究的目的是:1)研究是否与年龄相关的LC 3-Atg 16 l1 mRNA结合减少
导致Atg 16 l1 mRNA水平降低和自噬失败,2)确定LC 3-
通过使用新的LC 3突变体在体外介导的Atg 16 l1 mRNA稳定性,以及新的RRRLC 3QQQ突变体,
小鼠,其中三重精氨酸(RRR)基序在LC 3中,我们建议允许LC 3-Atg 16 l1 mRNA
结合,已被灭活,和3)测试是否LC 3-II的遗传重建,在老年肝脏,
恢复Atg 16 l1 mRNA水平、自噬和脂质稳态。我们的研究将提供新的
自噬如何随着年龄的增长而减少,并提供了一种新的策略,以防止自噬。
这一重要的质量控制途径随着年龄的增长而下降。
意义:老年人患多种疾病的风险增加,
神经变性、代谢综合征和癌症,仅举几例。研究损失
年轻小鼠中的自噬或小鼠中特定Atg基因的遗传过表达表明,
自噬在疾病预防中的重要作用。自噬如何随着年龄的增长而减少仍不清楚。
我们的研究将揭示一种通过增强Atg的稳定性来调控自噬的新机制
mRNA,Atg 16 l1,通过ATG蛋白,LC 3。了解自噬如何随着年龄的增长而减少至关重要
为了制定新的战略,以延长人类的健康寿命-
健康和活跃。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rajat Singh其他文献
Rajat Singh的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rajat Singh', 18)}}的其他基金
Integrative regulation of lipid sensing by mTOR
mTOR 对脂质传感的综合调节
- 批准号:
10674262 - 财政年份:2022
- 资助金额:
$ 25.05万 - 项目类别:
Circadian Mechanisms of Diabetes Prevention in Aged mice
老年小鼠糖尿病预防的昼夜节律机制
- 批准号:
10432031 - 财政年份:2019
- 资助金额:
$ 25.05万 - 项目类别:
Molecular regulation of gut lipid metabolism by mTOR and autophagy proteins
mTOR 和自噬蛋白对肠道脂质代谢的分子调节
- 批准号:
10454835 - 财政年份:2019
- 资助金额:
$ 25.05万 - 项目类别:
Molecular regulation of gut lipid metabolism by mTOR and autophagy proteins
mTOR 和自噬蛋白对肠道脂质代谢的分子调节
- 批准号:
10220024 - 财政年份:2019
- 资助金额:
$ 25.05万 - 项目类别:
Molecular regulation of gut lipid metabolism by mTOR and autophagy proteins
mTOR 和自噬蛋白对肠道脂质代谢的分子调节
- 批准号:
10079452 - 财政年份:2019
- 资助金额:
$ 25.05万 - 项目类别:
Molecular regulation of gut lipid metabolism by mTOR and autophagy proteins
mTOR 和自噬蛋白对肠道脂质代谢的分子调节
- 批准号:
10669617 - 财政年份:2019
- 资助金额:
$ 25.05万 - 项目类别:
Circadian Mechanisms of Diabetes Prevention in Aged mice
老年小鼠糖尿病预防的昼夜节律机制
- 批准号:
10782864 - 财政年份:2019
- 资助金额:
$ 25.05万 - 项目类别:
Circadian Mechanisms of Diabetes Prevention in Aged mice
老年小鼠糖尿病预防的昼夜节律机制
- 批准号:
10183131 - 财政年份:2019
- 资助金额:
$ 25.05万 - 项目类别:
Circadian Mechanisms of Diabetes Prevention in Aged mice
老年小鼠糖尿病预防的昼夜节律机制
- 批准号:
10018628 - 财政年份:2019
- 资助金额:
$ 25.05万 - 项目类别:
Hypothalamic autophagy and metabolic regulation in aging
衰老过程中的下丘脑自噬和代谢调节
- 批准号:
9036919 - 财政年份:2013
- 资助金额:
$ 25.05万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Determining the mechanism of action of cis-acting modifiers on the age of onset of Huntington Disease
确定顺式作用修饰剂对亨廷顿病发病年龄的作用机制
- 批准号:
417256 - 财政年份:2019
- 资助金额:
$ 25.05万 - 项目类别:
Studentship Programs
Effect of age of onset of contraception use on brain functioning.
避孕开始年龄对大脑功能的影响。
- 批准号:
511267-2017 - 财政年份:2017
- 资助金额:
$ 25.05万 - 项目类别:
University Undergraduate Student Research Awards
Non-random occurrence and early age of onset of diverse lymphoid cancers in families supports the existence of genetic risk factors for multiple lymphoid cancers.
家族中多种淋巴癌的非随机发生和发病年龄较早,支持多种淋巴癌存在遗传危险因素。
- 批准号:
347105 - 财政年份:2016
- 资助金额:
$ 25.05万 - 项目类别:
Polish-German Child Bilingualism: The Role of Age of Onset for Long-Term Achievement
波兰-德国儿童双语:发病年龄对长期成就的作用
- 批准号:
277135691 - 财政年份:2015
- 资助金额:
$ 25.05万 - 项目类别:
Research Grants
Bioinformatics strategies to relate age of onset with gene-gene interaction
将发病年龄与基因间相互作用联系起来的生物信息学策略
- 批准号:
9097781 - 财政年份:2015
- 资助金额:
$ 25.05万 - 项目类别:
Early Age-of-Onset AD: Clinical Heterogeneity and Network Degeneration
早期 AD 发病年龄:临床异质性和网络退化
- 批准号:
9212684 - 财政年份:2014
- 资助金额:
$ 25.05万 - 项目类别:
Early Age-of-Onset AD: Clinical Heterogeneity and Network Degeneration
早期 AD 发病年龄:临床异质性和网络退化
- 批准号:
8696557 - 财政年份:2014
- 资助金额:
$ 25.05万 - 项目类别:
Effects of delaying age of onset of binge drinking on adolescent brain development: A proposal to add neuroimaing measures to the CO-Venture Trial.
延迟酗酒的发病年龄对青少年大脑发育的影响:在 CO-Venture 试验中添加神经影像测量的建议。
- 批准号:
267251 - 财政年份:2012
- 资助金额:
$ 25.05万 - 项目类别:
Operating Grants
Stress Effects on Alcohol Consumption: Age of onset and genes in heavy drinkers
压力对饮酒的影响:酗酒者的发病年龄和基因
- 批准号:
8606722 - 财政年份:2012
- 资助金额:
$ 25.05万 - 项目类别:
Marijuana: Neurobiologic Correlates of Age of Onset
大麻:发病年龄的神经生物学相关性
- 批准号:
8644793 - 财政年份:2012
- 资助金额:
$ 25.05万 - 项目类别: